Rasmus Siersbaek
Robinson Way
Cambridge, ENG, United Kingdom
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Stochastic demethylation and redundant epigenetic suppressive mechanisms generate highly heterogeneous responses to pharmacological DNA methyltransferase inhibition.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 03, 2024
SWI/SNF Functions as a Gatekeeper of Enhancer Chromatin Access to Control Progression of Mesenchymal Triple-Negative Breast Cancer.
Journal: Cancer research
Published: May 17, 2024
Propionate reinforces epithelial identity and reduces aggressiveness of lung carcinoma.
Journal: EMBO molecular medicine
Published: April 11, 2023
MYC activity at enhancers drives prognostic transcriptional programs through an epigenetic switch.
Journal: Nature genetics
Published: February 22, 2023
TET2 is a component of the estrogen receptor complex and controls 5mC to 5hmC conversion at estrogen receptor cis-regulatory regions.
Journal: Cell reports
Published: June 26, 2020
Author Correction: ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response.
Journal: Nature genetics
Published: February 02, 2020
IL6/STAT3 Signaling Hijacks Estrogen Receptor α Enhancers to Drive Breast Cancer Metastasis.
Journal: Cancer cell
Published: August 09, 2019
Identification of ChIP-seq and RIME grade antibodies for Estrogen Receptor alpha.
Journal: PloS one
Published: February 13, 2019
Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancer.
Journal: Genes & development
Published: September 06, 2018
Last Updated: 09/26/2026